Jilteza

Metformin, the active ingredient in Jilteza, is a biguanide presented as an unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by decreasing hepatic glucose production and increasing peripheral insulin sensitivity, thereby improving overall glycemic control.

GNH USA supplies Jilteza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company adheres to stringent manufacturing standards and provides reliable logistics support.

Metformin, the generic name for Jilteza, is used in the management of disorders related to glucose metabolism. - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes. - Polycystic ovary syndrome: helps restore ovulation and improve insulin resistance.

Metformin may cause a range of adverse reactions, most of which are related to the gastrointestinal system or metabolic disturbances.

Common Side Effects: - Nausea: mild to moderate stomach discomfort. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal buildup of lactate. - Severe skin reactions (Stevens‑Johnson syndrome): life‑threatening rash. - Hepatic dysfunction: signs of liver injury. - Vitamin B12 deficiency: long‑term use may reduce B12 levels.

Before initiating therapy, several safety considerations should be addressed. - Renal function assessment: evaluate creatinine clearance prior to use. - Hepatic function monitoring: check liver enzymes periodically. - Risk of lactic acidosis: avoid in patients with severe heart failure or hypoxia. - Use caution in elderly: start with lower doses and monitor tolerance. - Contraindicated in severe renal impairment: do not use if eGFR <30 mL/min/1.73 m². - Store at room temperature: keep in original container, protect from moisture.

Metformin interacts with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: excessive intake heightens lactic acidosis potential.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Thiazide diuretics: may increase risk of hypoglycemia. - NSAIDs: can reduce renal clearance of metformin.